These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 596847)

  • 1. [Influence of the conditions of crystallization of the tetracycline base on the properties of the powders and medicinal forms produced. Influence of the dispersion of tetracycline powder on its techologic characteristics].
    Lin'kov GI; Ezerskiĭ ML; Zhukovskaia SA
    Antibiotiki; 1977 Nov; 22(11):984-9. PubMed ID: 596847
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of the crystallization conditions of tetracycline base on the properties of the powders and drug forms obtained. The dependence of the degree of dispersion of tetracycline base on the crystallization conditions].
    Lin'kov GI; Zhukovskaia SA; Dzhabarov DN; Nabokov VS
    Antibiotiki; 1977 Sep; 22(9):841-6. PubMed ID: 20836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of tetracycline base crystallization on the conditions properties of the powders and drug forms obtained. The development of directed crystallization procedures for tetracycline base].
    Lin'kov GI; Zhukovskaia SA
    Antibiotiki; 1977 Aug; 22(8):678-83. PubMed ID: 20834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of the tetracycline base crystallization conditions on the properties of the powders and drug forms obtained. Relationship between the dispersity of the tetracycline powder and the biological availability in capsules].
    Lin'kov GI; Okhotnikova VF; Koroleva VG; Nabokov VS; Zhuskovskaia SA
    Antibiotiki; 1978 Feb; 23(2):174-8. PubMed ID: 629528
    [No Abstract]   [Full Text] [Related]  

  • 5. [Determination of the color of tetracycline powders by instrumental methods].
    Kartseva VD; Faĭnberg IS; Bruks BP; Davydova IE; Kruzhkova NG
    Antibiotiki; 1973 Jul; 18(7):618-21. PubMed ID: 4773825
    [No Abstract]   [Full Text] [Related]  

  • 6. Optimisation of powders for pulmonary delivery using supercritical fluid technology.
    Rehman M; Shekunov BY; York P; Lechuga-Ballesteros D; Miller DP; Tan T; Colthorpe P
    Eur J Pharm Sci; 2004 May; 22(1):1-17. PubMed ID: 15113578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Properties and stability of tetracycline hydrochloride tablets].
    Nesterova LIa; Donskaia NG; Shadyro LL; Grakovskaia LK
    Antibiotiki; 1978 Jan; 23(1):62-6. PubMed ID: 623449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of milling conditions on the solid-state conversion of ranitidine hydrochloride form 1.
    Chieng N; Zujovic Z; Bowmaker G; Rades T; Saville D
    Int J Pharm; 2006 Dec; 327(1-2):36-44. PubMed ID: 16949221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Powder specific active dispersion for generation of pharmaceutical aerosols.
    Crowder T; Hickey A
    Int J Pharm; 2006 Dec; 327(1-2):65-72. PubMed ID: 16930884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spheroidization of glass powders for glass ionomer cements.
    Gu YW; Yap AU; Cheang P; Kumar R
    Biomaterials; 2004 Aug; 25(18):4029-35. PubMed ID: 15046893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transformation of lactulose trihydrate into anhydrous lactulose by fluidized bed drying and its characterization.
    Mizota T; Seki N; Kokubo S
    Carbohydr Res; 2004 Apr; 339(6):1069-75. PubMed ID: 15063193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of the method of blending an antibiotic powder with an acrylic bone cement powder on physical, mechanical, and thermal properties of the cured cement.
    Lewis G; Janna S; Bhattaram A
    Biomaterials; 2005 Jul; 26(20):4317-25. PubMed ID: 15683656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of surface composition on the flowability of industrial spray-dried dairy powders.
    Kim EH; Chen XD; Pearce D
    Colloids Surf B Biointerfaces; 2005 Dec; 46(3):182-7. PubMed ID: 16337780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aerosolization properties, surface composition and physical state of spray-dried protein powders.
    Bosquillon C; Rouxhet PG; Ahimou F; Simon D; Culot C; Préat V; Vanbever R
    J Control Release; 2004 Oct; 99(3):357-67. PubMed ID: 15451594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microstructure and mechanical properties of plasma sprayed HA/YSZ/Ti-6Al-4V composite coatings.
    Khor KA; Gu YW; Pan D; Cheang P
    Biomaterials; 2004 Aug; 25(18):4009-17. PubMed ID: 15046891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystallization kinetics of amorphous lactose, whey-permeate and whey powders.
    Ibach A; Kind M
    Carbohydr Res; 2007 Jul; 342(10):1357-65. PubMed ID: 17445785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of auxiliary substances on the bioavailability of tetracycline hydrochloride capsules (an in vitro study)].
    Grakovskaia LK; Nesterova LIa; Okhotnikova VF; Zak AF; Ermolova OB
    Antibiotiki; 1978 Mar; 23(3):215-9. PubMed ID: 637528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of particle properties on the flowability of ibuprofen powders.
    Liu LX; Marziano I; Bentham AC; Litster JD; White ET; Howes T
    Int J Pharm; 2008 Oct; 362(1-2):109-17. PubMed ID: 18652883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of the aerosolization properties of an inhalation dry powder based on selection of excipients.
    Minne A; Boireau H; Horta MJ; Vanbever R
    Eur J Pharm Biopharm; 2008 Nov; 70(3):839-44. PubMed ID: 18620052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of absorption enhancers to enhance the dispersibility of spray-dried powders for pulmonary gene therapy.
    Li HY; Seville PC; Williamson IJ; Birchall JC
    J Gene Med; 2005 Aug; 7(8):1035-43. PubMed ID: 15756712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.